Toshiba, which developed the diagnosis method with the National Cancer Center Research Institute and Tokyo Medical University, hopes to commercialize it in "several years" after beginning a trial next year. The method could be used to promote treatment of cancers from their early stage, it said. Read more.....                     Source:                                                                                                         November 25 2019